Seroprevalence to influenza A(H1N1) 2009 virus - Where are we?

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1205-1212

  Broberg, Eeva ^a   Nicoll, Angus ^a   Amato Gauci, Andrew ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS NUCLEOPROTEIN;

2009 H1N1 INFLUENZA; AGE DISTRIBUTION; ANTIBODY TITER; CROSS REACTION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOLOGICAL MEMORY; INFECTION RATE; INFLUENZA VACCINATION; NOSE SMEAR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROEPIDEMIOLOGY; SEROPREVALENCE; SHORT SURVEY; THROAT CULTURE; VIRUS NEUTRALIZATION; VIRUS SHEDDING; VIRUS STRAIN; VIRUS TRANSMISSION; VULNERABLE POPULATION;

AGE FACTORS; ANTIBODIES, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PANDEMICS; SEROEPIDEMIOLOGIC STUDIES;

EID: 79961109287     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05072-11     Document Type: Short Survey

References (41)

1. Adamson, W. E., et al. 2010. Pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill. 15(24):19590.
2. Aho, M., et al. 2010. Outbreak of 2009 pandemic influenza A(H1N1) in a Finnish garrison - a serological survey. Euro Surveill. 15(45):19709.
3. Allwinn, R., J. Geiler, A. Berger, J. Cinatl, and H. W. Doerr. 2010. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med. Microbiol. Immunol. 199:117-121.
4. Baker, M., H. Kelly, and N. Wilson. 2009. Pandemic H1N1 influenza lessons from the southern hemisphere. Euro Surveill. 14(42):19370.
5. Bandaranayake, D., et al. 2010. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 5:e13211.
6. CDC. 2009. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb. Mortal. Wkly. Rep. 58:521-524.
7. Chan, Y. J., et al. 2010. Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J. Chin. Med. Assoc. 73:62-66.
8. Chen, H., et al. 2009. Serologic survey of pandemic (H1N1) 2009 virus, Guangxi Province, China. Emerg. Infect. Dis. 15:1849-1850.
9. Chen, M. I., et al. 2010. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA 303:1383-1391.
10. Cowling, B. J., et al. 2010. Comparative epidemiology of pandemic and seasonal influenza A in households. N. Engl. J. Med. 362:2175-2184.
11. Dawood, F. S., et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360:2605-2615.
12. Duvvuri, V. R., et al. 2010. Highly conserved cross-reactive CD4+ T-cell HA-epitopes of seasonal and the 2009 pandemic influenza viruses. Influenza Other Respi. Viruses 4:249-258.
13. Gilbert, G. L., et al. 2010. Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5:e12562.
14. Gras, S., et al. 2010. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses. Proc. Natl. Acad. Sci. U. S. A. 107:12599-12604.
15. Hancock, K., et al. 2009. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361:1945-1952.
16. Hardelid, P., et al. 2010. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol. Assess. 14:115-192.
17. Hayward. A., et al. 2010. Flu Watch - National Community Cohort Study of influenza infection in England - 2006-2010, abstr. O-846. Options for the Control of Influenza VII, 3 to 7 September 2010. Hong Kong SAR, China.
18. Huang, D. T., et al. 2011. Serologic status for pandemic (H1N1) 2009 virus, Taiwan. Emerg. Infect. Dis. 17:76-78.
19. Ikonen, N., et al. 2010. High frequency of cross-reacting antibodies against 2009 pandemic influenza A(H1N1) virus among the elderly in Finland. Euro Surveill. 15(5):19478.
20. Itoh, Y., et al. 2009. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460:1021-1025.
21. Kanegae, Y., S. Sugita, K. F. Shortridge, Y. Yoshioka, and K. Nerome. 1994. Origin and evolutionary pathways of the H1 hemagglutinin gene of avian, swine and human influenza viruses: cocirculation of two distinct lineages of swine virus. Arch. Virol. 134:17-28. (Pubitemid 2027012)
22. Lim, M., et al. 2010. Flu Watch - community burden of influenza during three inter-pandemic influenza seasons and the summer wave of the 2009 H1N1 pandemic in England - implications for interpretation of surveillance data, poster P-321. Options for the Control of Influenza VII, 3 to 7 September 2010. Hong Kong SAR, China.
23. Mazick, A., et al. 2010. Higher all-cause mortality in children during autumn 2009 compared with the three previous years: pooled results from eight European countries. Euro Surveill. 15(5):19480.
24. McBryde, E., et al. 2009. Early transmission characteristics of influenza A(H1N1)v in Australia: Victorian state, 16 May - 3 June 2009. Euro Surveill. 14(42):19363.
25. McCullers, J. A., et al. 2010. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin. Infect. Dis. 50:1487-1492.
26. McVernon, J., et al. 2010. Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October - December 2009. Euro Surveill. 15(40):19678.
27. Miller, E., et al. 2010. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375:1100-1108.
28. Monsalvo, A. C., et al. 2011. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 17:195-199.
29. Nicoll, A., et al. 2010. Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health 124:14-23.
30. Nicoll, A., and M. McKee. 2010. Moderate pandemic, not many dead - learning the right lessons in Europe from the 2009 pandemic. Eur. J. Public Health 20:486-488.
31. Rizzo, C., et al. 2010. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 28:3558-3562.
32. Stephenson, I., et al. 2009. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg. Infect. Dis. 15:1252-1259.
33. Tang, J. W., et al. 2010. Cross-reactive antibodies to pandemic (H1N1) 2009 virus, Singapore. Emerg. Infect. Dis. 16:874-876.
34. Tsai, T. F., et al. 2010. Regional and age-specific patterns of pandemic H1N1 influenza virus seroprevalence inferred from vaccine clinical trials, August-October 2009. Euro Surveill. 15(30):19624.
35. Tu, W., et al. 2010. Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. J. Virol. 84:6527-6535.
36. Waalen, K., et al. 2010. High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill. 15(31):19633.
37. WHO. 2010. Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus. Wkly. Epidemiol. Rec. 85:229-235.
38. Wood, J. M., R. E. Gaines-Das, J. Taylor, and P. Chakraverty. 1994. Comparison of influenza serological techniques by international collaborative study. Vaccine 12:167-174. (Pubitemid 24041936)
39. Wu, J. T., et al. 2010. The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin. Infect. Dis. 51:1184-1191.
40. Yu, X., et al. 2008. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455:532-536.
41. Zimmer, S. M., et al. 2010. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 5:e11601.